RECRUITING

Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to find out how cancer treatments (chemotherapy and/or radiation therapy) affect reproductive and sexual health in people with early onset colorectal cancer. The study researchers will observe and track changes in hormone levels and in sexual and reproductive health in people with early onset colorectal cancer. This information will help researchers know more about how cancer treatments affect reproductive and sexual health, including the ability to have children (fertility).

Official Title

The Effects of Chemotherapy or Radiotherapy on Reproductive and Sexual Health of Early Onset Colorectal Cancer Patients

Quick Facts

Study Start:2021-03-18
Study Completion:2025-03-18
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04812912

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 50 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18-40 years of age and premenopausal (female) or 18-50 years of age (male) at time of diagnosis
  2. * Histologic diagnosis of colorectal adenocarcinoma
  3. * Able and willing to participate in the informed consent process
  4. * Eligible for curative adjuvant or neoadjuvant therapy for colon or rectal cancer
  5. * Willing and able to complete protocol questionnaires
  6. * Rectal patients only: Individuals who will be receiving chemotherapy, followed by chemoradiotherapy (ChemoRT)
  1. * Prior systemic treatment for this malignancy
  2. * Active or prior secondary malignancy
  3. * History of ovarian resection (if female)
  4. * Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception until the termination of gestation, confirmed by a positive hCG laboratory test.

Contacts and Locations

Study Contact

Andrea Cercek, MD
CONTACT
646-888-4189
cerceka@mskcc.org
Paul Romesser, MD
CONTACT
646-888-2118
romessep@mskcc.org

Principal Investigator

Andrea Cercek, MD
PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center

Study Locations (Sites)

Hartford Healthcare Cancer Alliance (Data collection only)
Hartford, Connecticut, 06102
United States
Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, 07920
United States
Memorial Sloan Kettering Monmouth
Middletown, New Jersey, 07748
United States
Memorial Sloan Kettering Bergen
Montvale, New Jersey, 07645
United States
Memorial Sloan Kettering Cancer Center at Suffolk - Commack
Commack, New York, 11725
United States
Memorial Sloan Kettering Westchester
Harrison, New York, 10604
United States
Memorial Sloan Kettering Cancer Center
New York, New York, 10065
United States
Memorial Sloan Kettering Nassau
Rockville Centre, New York, 11553
United States

Collaborators and Investigators

Sponsor: Memorial Sloan Kettering Cancer Center

  • Andrea Cercek, MD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-03-18
Study Completion Date2025-03-18

Study Record Updates

Study Start Date2021-03-18
Study Completion Date2025-03-18

Terms related to this study

Keywords Provided by Researchers

  • Early Onset Colorectal Cancer
  • Colorectal Cancer
  • 21-035
  • Memorial Sloan Kettering Cancer Center

Additional Relevant MeSH Terms

  • Colorectal Cancer
  • Colorectal Neoplasms
  • Colorectal Carcinoma